Pharmacies - Tajikistan

  • Tajikistan
  • In Tajikistan, the revenue in the Pharmacies market is forecasted to reach US$99.88m in 2024.
  • It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 0.20%, leading to a market volume of US$100.90m by 2029.
  • When compared globally, United States is projected to generate the highest revenue of US$387.30bn in 2024.
  • In terms of per person revenues, in Tajikistan is estimated to generate US$9.67 in 2024.
  • The pharmacy market in Tajikistan is experiencing a surge in demand for traditional herbal remedies.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacies market in Tajikistan has been experiencing significant growth in recent years.

Customer preferences:
Customers in Tajikistan have shown a strong preference for purchasing healthcare products and medications from pharmacies. This is due to the convenience and accessibility that pharmacies provide, as well as the trust that customers have in the quality of products sold in pharmacies. Customers also value the professional advice and guidance that pharmacists can provide, especially when it comes to over-the-counter medications.

Trends in the market:
One of the key trends in the Pharmacies market in Tajikistan is the increasing demand for generic medications. This trend can be attributed to the rising healthcare costs and the need for more affordable treatment options. Customers are becoming more aware of the availability and effectiveness of generic medications, and are choosing them over brand-name drugs. This trend is also driven by the government's efforts to promote the use of generic medications as a cost-saving measure. Another trend in the market is the growing demand for natural and herbal remedies. Customers are increasingly seeking alternative healthcare options and are turning to natural and herbal products for their health needs. This trend is driven by a growing awareness of the potential side effects of conventional medications, as well as a desire for more holistic approaches to healthcare. Pharmacies are responding to this trend by expanding their product offerings to include a wider range of natural and herbal remedies.

Local special circumstances:
Tajikistan is a developing country with a growing population and an increasing burden of chronic diseases. This has led to a higher demand for healthcare products and medications, which in turn has contributed to the growth of the Pharmacies market. Additionally, Tajikistan has a relatively underdeveloped healthcare infrastructure, with limited access to hospitals and clinics in rural areas. As a result, pharmacies play a crucial role in providing healthcare services and products to the population.

Underlying macroeconomic factors:
The growth of the Pharmacies market in Tajikistan can be attributed to several underlying macroeconomic factors. Firstly, the country has experienced stable economic growth in recent years, which has increased disposable incomes and improved living standards. This has led to an increase in healthcare spending, including spending on medications and healthcare products. Secondly, the government of Tajikistan has been implementing healthcare reforms aimed at improving access to healthcare services and ensuring the availability of affordable medications. These reforms have included measures to regulate and standardize the pharmaceutical sector, as well as initiatives to promote the use of generic medications. These government efforts have created a favorable business environment for pharmacies and have contributed to the growth of the market. In conclusion, the Pharmacies market in Tajikistan is experiencing significant growth due to customer preferences for convenience and accessibility, as well as the increasing demand for generic medications and natural remedies. The local special circumstances, such as the underdeveloped healthcare infrastructure and the burden of chronic diseases, have also contributed to the growth of the market. Furthermore, underlying macroeconomic factors, such as stable economic growth and government healthcare reforms, have created a favorable business environment for pharmacies in Tajikistan.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Users
  • Volume
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)